Hansyn Pharma is a private high-tech pharmaceutical organization, with major share holders of ‘Hengchang Investment’ under Jiangsu Huachang Group, and ‘Winfast Holding’ in Nanjing, consisting of a manufacturing site in Zhangjiagang Yangtze River International Industrial Park and a new established R&D and business center located in Juke High-tech Park, Shanghai. Hansyn Pharma is under rapid expansion currently and has over 300 employees leading by a core management team with the combination of oversea returnees and local talents. The business focus is to provide the optimum integrated services and products for Regulated Sourcing, Contract Research & Development (CRO) and Custom Manufacturing (CMO) to pharmaceutical industry. With its experience and expertise in pharmaceutical and chemistry, the company is striving to offer value synergies and innovations to customers via sustainable partnership in key therapeutic areas including respiratory, metabolism and diabetes etc.